Breast Cancer Screening Blood Test (EG-Breast Blood Test-P1)
EG-Breast Blood Test-P1 is a non-invasive test for screening breast cancer recurrence or metastasis. Using just 8 milliliters of blood, it supports better treatment decisions and avoids the discomfort of traditional exams, making it ideal for women who fear pain or have had breast surgery.
Target Audience
- Patients who have had breast cancer
- Patients currently undergoing breast cancer treatment
- Post-surgery breast cancer follow-up patients
- Individuals with a family history of breast cancer (e.g., BRCA1 or BRCA2 gene mutations)
- Those seeking an easier and more comfortable monitoring option (especially for those who find traditional breast exams uncomfortable)
Clinical Analysis: Over 500 Cases
Sensitivity: 95.7%
Specificity: 90.3%
Accuracy: 95.4%
Certifications and Approvals
🏆 Certified with ISO 15189 and LDTs standards. 🏆
A New Approach to Early Pancreatic Cancer Diagnosis
The 2018 NCCN guidelines recommend follow-up visits 1 to 4 times a year for the first 5 years after cancer treatment, then annually. ASCO guidelines suggest follow-ups every 3 to 6 months for the first 3 years, every 6 to 12 months for the next 2 years, and annually after 5 years.
These guidelines should be adjusted based on individual patient needs and should be arranged by the attending physician.
